
Keywords: Cost-effectiveness analysis; Deep brain stimulation; Economic analysis; Parkinson disease; BMT; Best medical treatment; CDLCI; Continuous duodenal levodopa carbidopa infusion; CSAI; Continuous subcutaneous apomorphine infusion; DBS; Deep brain stimulation